The leading source of independent data and intelligence for the psychedelics industry.
On January 5, 2022, Health Canada made effective amendments to Canada’s special access programs (SAP’s). These amendments allow medical practitioners to request access to certain psychedelics for eligible patients. These amendments to the SAP now …
Numinus Wellness Inc. announced its fiscal fourth quarter and full-year results Thursday. They achieved an increase in revenue of 81% from the same period year ago. The Vancouver, British Columbia-based company noted that revenue was …
A Bit of a Preamble The world of psychedelics has been a bit of a rough ride lately, and it’s hard to always find positive stories. So we decided to take a bit of time …
Sanjay Singhal, a successful Canadian entrepreneur, is on a mission to transform mental health care. Creating Canada’s first psychedelic psychotherapy research center for mental health, housed out of Toronto’s University Health Network. Snajay hopes that …
While most psychedelic drugs remain illegal in the United States, ketamine has been legal for use by registered practitioners since the 1960s. With the recent recognition of the compound’s use as an antidepressant, more and …
Delix Therapeutics, a Boston-based startup just hit the jackpot on their initial funding round. They raised $70M to continue their research on removing the “tripping” effects from psychedelic. All with the end goal of using …
It is no secret that COMPASS reached unicorn status in the psychedelic space when it recently IPO’d. With that status came a market leader moniker. And that trend continues as they set their sights on …
COMPASS Pathways has recently engaged with Hamilton Morris, a research scientist and film-maker, as a full-time consultant. Mr. Morris will be working at the COMPASS Discovery Center at the University of the Sciences in Philadelphia. …
This Is Your Brain On Drugs A research team from Yale has been exploring the effects of psychedelics on the brain. Their research has shown that a single dose of psilocybin is enough to cause …
</pre> Getting Under the Skin As more and more research hints at the potential therapeutic uses of psychedelics, finding new ways to deliver the powerful drugs has taken on new interest. Commonly administered forms of …